Merck’s drug for bacterial infection leads to fatal diarrhea
merck
December, 24 2024
(Web Desk) Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.
The antibody drug, Zinplava, was first approved by the regulator in 2016 to prevent the recurrence of Clostridioides difficile infections (CDI).
CDI is generally caused by prolonged use of antibiotics, and can lead to potentially fatal diarrhea and inflammation of the colon.
The drugmaker did not immediately comment on the matter.
Zinplava will be discontinued on Jan. 31, the regulator s website showed, but no reason was cited for the decision.
Must Read
Los Angeles home that survived wildfire is split in half by landslide
January, 17 2025
What did Holy Prophet (SAW) 'say to Dr Aafia Siddiqui in her dream?'
January, 15 2025
Unbelievable benefits of drinking warm water (not hot water)
January, 15 2025
Why are most scientists atheists? American scientist explains
January, 10 2025